These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1441675)

  • 1. Enteric protein loss as a marker of intestinal inflammatory activity in Crohn's disease: comparability of enteric clearance and stool concentration of alpha-1-antitrypsin?
    Hundegger K; Stufler M; Karbach U
    Z Gastroenterol; 1992 Oct; 30(10):722-8. PubMed ID: 1441675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Initial personal experiences with alpha-1-antitrypsin determination in feces].
    Schwery S; Meyenberger C; Ammann R; Wirth HP
    Schweiz Med Wochenschr; 1995 Sep; 125(38):1783-7. PubMed ID: 7481635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal excretion of alpha 2-macroglobulin: a novel marker for disease activity in patients with inflammatory bowel disease.
    Becker K; Niederau C; Frieling T
    Z Gastroenterol; 1999 Jul; 37(7):597-605. PubMed ID: 10458008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simplified determination of intestinal protein excretion based on alpha 1-antitrypsin clearance.
    Karbach U; Singe CC; Ewe K
    Z Gastroenterol; 1988 Mar; 26(3):169-73. PubMed ID: 3261475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enteric protein loss in various gastrointestinal diseases determined by intestinal alpha 1-antitrypsin clearance.
    Karbach U; Ewe K
    Z Gastroenterol; 1989 Jul; 27(7):362-5. PubMed ID: 2475983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fecal excretion and the clearance of alpha 1-antitrypsin in patients with Crohn's disease].
    López A; Hinojosa J; Miralles A; Primo J; Bermúdez JD
    Rev Esp Enferm Dig; 1993 Apr; 83(4):235-9. PubMed ID: 8494651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individual fecal alpha 1-antitrypsin excretion reflects clinical activity in Crohn's disease but not in ulcerative colitis.
    Becker K; Berger M; Niederau C; Frieling T
    Hepatogastroenterology; 1999; 46(28):2309-14. PubMed ID: 10521988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Qualitative study of fecal alpha-1-antitrypsin in patients with inflammatory digestive disease and patients with ileostomy].
    Colombel JF; Mizon C; Chekkouri N; Balduyck M; Chaussade S; Becuwe C; Degand P; Mizon J; Cortot A
    Gastroenterol Clin Biol; 1991; 15(4):301-5. PubMed ID: 2060740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Random fecal alpha-1-antitrypsin concentration in children with gastrointestinal disease.
    Thomas DW; Sinatra FR; Merritt RJ
    Gastroenterology; 1981 Apr; 80(4):776-82. PubMed ID: 6970702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Alpha 1-antitrypsin as an endogenous marker of protein-losing enteropathies].
    Kulesza E; Lisowska B; Tomaszewski L; Dobrowolski W; Socha J
    Pol Tyg Lek; 1992 Jan 20-27; 47(3-4):98-101. PubMed ID: 1437795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal clearance of alpha 1-antitrypsin. A sensitive method for the detection of protein-losing enteropathy.
    Florent C; L'Hirondel C; Desmazures C; Aymes C; Bernier JJ
    Gastroenterology; 1981 Oct; 81(4):777-80. PubMed ID: 6973500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha 1-antitrypsin clearance as an aid in the management of patients with celiac disease.
    Bai JC; Sambuelli A; Niveloni S; Sugai E; Mazure R; Kogan Z; Pedreira S; Boerr L
    Am J Gastroenterol; 1991 Aug; 86(8):986-91. PubMed ID: 1858765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Investigation of protein-losing enteropathy in pediatric patients].
    Sierra Salinas C; Vicioso Recio MI; Barco Galvez A; del Rio Mapelli L; Martinez Valverde A
    An Esp Pediatr; 1997 Aug; 47(2):144-50. PubMed ID: 9382345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal eosinophil granule-derived proteins reflect disease activity in inflammatory bowel disease.
    Saitoh O; Kojima K; Sugi K; Matsuse R; Uchida K; Tabata K; Nakagawa K; Kayazawa M; Hirata I; Katsu K
    Am J Gastroenterol; 1999 Dec; 94(12):3513-20. PubMed ID: 10606313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Initial clinical experiences with a simplified analytic method for fecal alpha-1-antitrypsin].
    Fischbach W; Deubel M; Boege F; Mössner J
    Z Gastroenterol; 1991 Dec; 29(12):650-4. PubMed ID: 1771947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal lactoferrin as a marker for disease activity in inflammatory bowel disease: comparison with other neutrophil-derived proteins.
    Sugi K; Saitoh O; Hirata I; Katsu K
    Am J Gastroenterol; 1996 May; 91(5):927-34. PubMed ID: 8633583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enteric protein loss during shigellosis.
    Bennish ML; Salam MA; Wahed MA
    Am J Gastroenterol; 1993 Jan; 88(1):53-7. PubMed ID: 8420274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graft-versus-host disease of the intestine: a protein losing enteropathy characterized by fecal alpha 1-antitrypsin.
    Weisdorf SA; Salati LM; Longsdorf JA; Ramsay NK; Sharp HL
    Gastroenterology; 1983 Nov; 85(5):1076-81. PubMed ID: 6352387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Increased serum alpha 1-antitrypsin does not produce a rise in fecal alpha 1-antitrypsin in patients with healthy intestines].
    Stufler MH; Ewe K; Gierlasinski B; Prün H; Zutt M
    Z Gastroenterol; 1991 Jan; 29(1):11-5. PubMed ID: 2058223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal loss and clearance of alpha-1-antitrypsin in children with persistent diarrhea.
    Duarte MA; Carneiro SM; Melo MC; Penna FJ
    Braz J Med Biol Res; 1994 Jul; 27(7):1553-60. PubMed ID: 7874022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.